{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T04:02:03Z","timestamp":1785124923546,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Social Science and Technology Development Project of Jiangning District Science and Technology Bureau, Nanjing City","award":["2019SHSY0034"],"award-info":[{"award-number":["2019SHSY0034"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03310-w","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:29:52Z","timestamp":1783488592000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["IFITM3 promotes an M2-like tumor-supportive microenvironment in acute myeloid leukemia"],"prefix":"10.1007","volume":"43","author":[{"given":"Fang","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JiaHeng","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"issue":"1","key":"3310_CR1","doi-asserted-by":"publisher","first-page":"102741","DOI":"10.1016\/j.jbc.2022.102741","volume":"299","author":"M Gomez-Herranz","year":"2023","unstructured":"Gomez-Herranz M, Taylor J, Sloan RD. IFITM proteins: Understanding their diverse roles in viral infection, cancer, and immunity. J Biol Chem. 2023;299(1):102741.","journal-title":"J Biol Chem"},{"issue":"7","key":"3310_CR2","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41419-019-1750-7","volume":"10","author":"X Liu","year":"2019","unstructured":"Liu X, Chen L, Fan Y, Hong Y, Yang X, Li Y, et al. IFITM3 promotes bone metastasis of prostate cancer cells by mediating activation of the TGF-beta signaling pathway. Cell Death Dis. 2019;10(7):517.","journal-title":"Cell Death Dis"},{"issue":"1\u20132","key":"3310_CR3","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41417-019-0093-y","volume":"27","author":"Y Liu","year":"2020","unstructured":"Liu Y, Lu R, Cui W, Pang Y, Liu C, Cui L, et al. High IFITM3 expression predicts adverse prognosis in acute myeloid leukemia. Cancer Gene Ther. 2020;27(1\u20132):38\u201344.","journal-title":"Cancer Gene Ther"},{"issue":"1","key":"3310_CR4","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13578-022-00858-8","volume":"12","author":"PY Chu","year":"2022","unstructured":"Chu PY, Huang WC, Tung SL, Tsai CY, Chen CJ, Liu YC, et al. IFITM3 promotes malignant progression, cancer stemness and chemoresistance of gastric cancer by targeting MET\/AKT\/FOXO3\/c-MYC axis. Cell Biosci. 2022;12(1):124.","journal-title":"Cell Biosci"},{"issue":"8","key":"3310_CR5","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/2211-5463.12479","volume":"8","author":"J Min","year":"2018","unstructured":"Min J, Feng Q, Liao W, Liang Y, Gong C, Li E, et al. IFITM3 promotes hepatocellular carcinoma invasion and metastasis by regulating MMP9 through p38\/MAPK signaling. FEBS Open Bio. 2018;8(8):1299\u2013311.","journal-title":"FEBS Open Bio"},{"issue":"6","key":"3310_CR6","doi-asserted-by":"publisher","first-page":"523","DOI":"10.5582\/bst.2019.01289","volume":"13","author":"J Min","year":"2020","unstructured":"Min J, Hu J, Luo C, Zhu J, Zhao J, Zhu Z, et al. IFITM3 upregulates c-myc expression to promote hepatocellular carcinoma proliferation via the ERK1\/2 signalling pathway. Biosci Trends. 2020;13(6):523\u20139.","journal-title":"Biosci Trends"},{"issue":"4","key":"3310_CR7","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1172\/JCI84889","volume":"127","author":"MA Stacey","year":"2017","unstructured":"Stacey MA, Clare S, Clement M, Marsden M, Abdul-Karim J, Kane L, et al. The antiviral restriction factor IFN-induced transmembrane protein 3 prevents cytokine-driven CMV pathogenesis. J Clin Invest. 2017;127(4):1463\u201374.","journal-title":"J Clin Invest"},{"issue":"1","key":"3310_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/eji.201847692","volume":"49","author":"DC Yanez","year":"2019","unstructured":"Yanez DC, Sahni H, Ross S, Solanki A, Lau CI, Papaioannou E, et al. IFITM proteins drive type 2 T helper cell differentiation and exacerbate allergic airway inflammation. Eur J Immunol. 2019;49(1):66\u201378.","journal-title":"Eur J Immunol"},{"issue":"1","key":"3310_CR9","doi-asserted-by":"publisher","first-page":"4999","DOI":"10.1038\/s41467-021-24982-0","volume":"12","author":"JMJ Tan","year":"2021","unstructured":"Tan JMJ, Garner ME, Regeimbal JM, Greene CJ, Marquez JDR, Ammendolia DA, et al. Listeria exploits IFITM3 to suppress antibacterial activity in phagocytes. Nat Commun. 2021;12(1):4999.","journal-title":"Nat Commun"},{"issue":"1","key":"3310_CR10","doi-asserted-by":"publisher","first-page":"5294","DOI":"10.1038\/s41467-022-32587-4","volume":"13","author":"M Clement","year":"2022","unstructured":"Clement M, Forbester JL, Marsden M, Sabberwal P, Sommerville MS, Wellington D, et al. IFITM3 restricts virus-induced inflammatory cytokine production by limiting Nogo-B mediated TLR responses. Nat Commun. 2022;13(1):5294.","journal-title":"Nat Commun"},{"key":"3310_CR11","doi-asserted-by":"publisher","first-page":"704965","DOI":"10.3389\/fimmu.2021.704965","volume":"12","author":"Y Cai","year":"2021","unstructured":"Cai Y, Ji W, Sun C, Xu R, Chen X, Deng Y, et al. Interferon-Induced Transmembrane Protein 3 Shapes an Inflamed Tumor Microenvironment and Identifies Immuno-Hot Tumors. Front Immunol. 2021;12:704965.","journal-title":"Front Immunol"},{"issue":"10","key":"3310_CR12","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.21037\/tau-21-848","volume":"10","author":"Y Xu","year":"2021","unstructured":"Xu Y, Huang D, Zhang K, Tang Z, Ma J, Zhu M, et al. Overexpressing IFITM family genes predict poor prognosis in kidney renal clear cell carcinoma. Transl Androl Urol. 2021;10(10):3837\u201351.","journal-title":"Transl Androl Urol"},{"issue":"1","key":"3310_CR13","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41467-023-44391-9","volume":"15","author":"X Liu","year":"2024","unstructured":"Liu X, Zhang W, Han Y, Cheng H, Liu Q, Ke S, et al. FOXP3(+) regulatory T cell perturbation mediated by the IFNgamma-STAT1-IFITM3 feedback loop is essential for anti-tumor immunity. Nat Commun. 2024;15(1):122.","journal-title":"Nat Commun"},{"issue":"9","key":"3310_CR14","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.1002\/jcp.26429","volume":"233","author":"A Shapouri-Moghaddam","year":"2018","unstructured":"Shapouri-Moghaddam A, Mohammadian S, Vazini H, Taghadosi M, Esmaeili SA, Mardani F, et al. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 2018;233(9):6425\u201340.","journal-title":"J Cell Physiol"},{"key":"3310_CR15","doi-asserted-by":"publisher","first-page":"173090","DOI":"10.1016\/j.ejphar.2020.173090","volume":"877","author":"C Yunna","year":"2020","unstructured":"Yunna C, Mengru H, Lei W, Weidong C. Macrophage M1\/M2 polarization. Eur J Pharmacol. 2020;877:173090.","journal-title":"Eur J Pharmacol"},{"key":"3310_CR16","doi-asserted-by":"publisher","first-page":"1412076","DOI":"10.3389\/fimmu.2024.1412076","volume":"15","author":"SM Park","year":"2024","unstructured":"Park SM, Chen CJ, Verdon DJ, Ooi MPY, Brooks AES, Martin RCW, et al. Proliferating macrophages in human tumours show characteristics of monocytes responding to myelopoietic growth factors. Front Immunol. 2024;15:1412076.","journal-title":"Front Immunol"},{"key":"3310_CR17","doi-asserted-by":"publisher","first-page":"1295442","DOI":"10.3389\/fphar.2023.1295442","volume":"14","author":"L Wu","year":"2023","unstructured":"Wu L, Xia W, Hua Y, Fan K, Lu Y, Wang M, et al. Cellular crosstalk of macrophages and therapeutic implications in non-small cell lung cancer revealed by integrative inference of single-cell transcriptomics. Front Pharmacol. 2023;14:1295442.","journal-title":"Front Pharmacol"},{"key":"3310_CR18","doi-asserted-by":"publisher","first-page":"642285","DOI":"10.3389\/fimmu.2021.642285","volume":"12","author":"TD Ricketts","year":"2021","unstructured":"Ricketts TD, Prieto-Dominguez N, Gowda PS, Ubil E. Mechanisms of Macrophage Plasticity in the Tumor Environment: Manipulating Activation State to Improve Outcomes. Front Immunol. 2021;12:642285.","journal-title":"Front Immunol"},{"key":"3310_CR19","doi-asserted-by":"publisher","first-page":"948098","DOI":"10.1155\/2012\/948098","volume":"2012","author":"NB Hao","year":"2012","unstructured":"Hao NB, Lu MH, Fan YH, Cao YL, Zhang ZR, Yang SM. Macrophages in tumor microenvironments and the progression of tumors. Clin Dev Immunol. 2012;2012:948098.","journal-title":"Clin Dev Immunol"},{"key":"3310_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/cancers13143597","volume":"13","author":"E Cencini","year":"2021","unstructured":"Cencini E, Fabbri A, Sicuranza A, Gozzetti A, Bocchia M. The Role of Tumor-Associated Macrophages in Hematologic Malignancies. Cancers (Basel). 2021;13:14.","journal-title":"Cancers (Basel)"},{"issue":"10","key":"3310_CR21","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.3390\/biomedicines12102306","volume":"12","author":"O Mesaros","year":"2024","unstructured":"Mesaros O, Onciul M, Matei E, Joldes C, Jimbu L, Neaga A, et al. Macrophages as Potential Therapeutic Targets in Acute Myeloid Leukemia. Biomedicines. 2024;12(10):2306.","journal-title":"Biomedicines"},{"issue":"1","key":"3310_CR22","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s13046-018-0938-5","volume":"37","author":"Y Li","year":"2018","unstructured":"Li Y, Cao F, Li M, Li P, Yu Y, Xiang L, et al. Hydroxychloroquine induced lung cancer suppression by enhancing chemo-sensitization and promoting the transition of M2-TAMs to M1-like macrophages. J Exp Clin Cancer Res. 2018;37(1):259.","journal-title":"J Exp Clin Cancer Res"},{"issue":"7","key":"3310_CR23","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1172\/JCI81603","volume":"126","author":"K Weiskopf","year":"2016","unstructured":"Weiskopf K, Jahchan NS, Schnorr PJ, Cristea S, Ring AM, Maute RL, et al. CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer. J Clin Invest. 2016;126(7):2610\u201320.","journal-title":"J Clin Invest"},{"issue":"11","key":"3310_CR24","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/nnano.2016.168","volume":"11","author":"S Zanganeh","year":"2016","unstructured":"Zanganeh S, Hutter G, Spitler R, Lenkov O, Mahmoudi M, Shaw A, et al. Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues. Nat Nanotechnol. 2016;11(11):986\u201394.","journal-title":"Nat Nanotechnol"},{"issue":"1","key":"3310_CR25","doi-asserted-by":"publisher","first-page":"5361","DOI":"10.1038\/s41467-018-07767-w","volume":"9","author":"Q Jia","year":"2018","unstructured":"Jia Q, Wu W, Wang Y, Alexander PB, Sun C, Gong Z, et al. Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer. Nat Commun. 2018;9(1):5361.","journal-title":"Nat Commun"},{"issue":"6","key":"3310_CR26","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","volume":"176","author":"P van Galen","year":"2019","unstructured":"van Galen P, Hovestadt V, Wadsworth Ii MH, Hughes TK, Griffin GK, Battaglia S, et al. Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity. Cell. 2019;176(6):1265\u2013e8124.","journal-title":"Cell"},{"issue":"1","key":"3310_CR27","doi-asserted-by":"publisher","first-page":"qiae178","DOI":"10.1093\/jleuko\/qiae178","volume":"117","author":"V Chaparro","year":"2024","unstructured":"Chaparro V, Leroux LP, Lebourg A, Chagneau S, Graber TE, Alain T, et al. Leukemia inhibitory factor drives transcriptional programs that promote lipid accumulation and M2 polarization in macrophages. J Leukoc Biol. 2024;117(1):qiae178.","journal-title":"J Leukoc Biol"},{"issue":"5","key":"3310_CR28","doi-asserted-by":"publisher","first-page":"7382","DOI":"10.3892\/mmr.2017.7511","volume":"16","author":"L Jiang","year":"2017","unstructured":"Jiang L, Li X, Zhang Y, Zhang M, Tang Z, Lv K. Microarray and bioinformatics analyses of gene expression profiles in BALB\/c murine macrophage polarization. Mol Med Rep. 2017;16(5):7382\u201390.","journal-title":"Mol Med Rep"},{"key":"3310_CR29","doi-asserted-by":"publisher","first-page":"1354735","DOI":"10.3389\/fimmu.2024.1354735","volume":"15","author":"F Zhang","year":"2024","unstructured":"Zhang F, Huang B, Utturkar SM, Luo W, Cresswell G, Herr SA, et al. Tumor-specific activation of folate receptor beta enables reprogramming of immune cells in the tumor microenvironment. Front Immunol. 2024;15:1354735.","journal-title":"Front Immunol"},{"issue":"44","key":"3310_CR30","doi-asserted-by":"publisher","first-page":"23268","DOI":"10.1074\/jbc.M116.754945","volume":"291","author":"JW Ashley","year":"2016","unstructured":"Ashley JW, Hancock WD, Nelson AJ, Bone RN, Tse HM, Wohltmann M, et al. Polarization of Macrophages toward M2 Phenotype Is Favored by Reduction in iPLA2beta (Group VIA Phospholipase A2). J Biol Chem. 2016;291(44):23268\u201381.","journal-title":"J Biol Chem"},{"issue":"1","key":"3310_CR31","doi-asserted-by":"publisher","first-page":"4353","DOI":"10.1038\/s41467-019-12384-2","volume":"10","author":"T Yu","year":"2019","unstructured":"Yu T, Gan S, Zhu Q, Dai D, Li N, Wang H, et al. Modulation of M2 macrophage polarization by the crosstalk between Stat6 and Trim24. Nat Commun. 2019;10(1):4353.","journal-title":"Nat Commun"},{"issue":"5","key":"3310_CR32","doi-asserted-by":"publisher","first-page":"109955","DOI":"10.1016\/j.celrep.2021.109955","volume":"37","author":"L He","year":"2021","unstructured":"He L, Jhong JH, Chen Q, Huang KY, Strittmatter K, Kreuzer J, et al. Global characterization of macrophage polarization mechanisms and identification of M2-type polarization inhibitors. Cell Rep. 2021;37(5):109955.","journal-title":"Cell Rep"},{"issue":"14","key":"3310_CR33","doi-asserted-by":"publisher","first-page":"e121157","DOI":"10.1172\/jci.insight.121157","volume":"3","author":"J Fourcade","year":"2018","unstructured":"Fourcade J, Sun Z, Chauvin JM, Ka M, Davar D, Pagliano O, et al. CD226 opposes TIGIT to disrupt Tregs in melanoma. JCI Insight. 2018;3(14):e121157.","journal-title":"JCI Insight"},{"key":"3310_CR34","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.3389\/fimmu.2019.02936","volume":"10","author":"SM Toor","year":"2019","unstructured":"Toor SM, Murshed K, Al-Dhaheri M, Khawar M, Abu Nada M, Elkord E. Immune Checkpoints in Circulating and Tumor-Infiltrating CD4(+) T Cell Subsets in Colorectal Cancer Patients. Front Immunol. 2019;10:2936.","journal-title":"Front Immunol"},{"issue":"22","key":"3310_CR35","doi-asserted-by":"publisher","first-page":"5685","DOI":"10.1158\/1078-0432.CCR-18-0554","volume":"24","author":"A Toker","year":"2018","unstructured":"Toker A, Nguyen LT, Stone SC, Yang SYC, Katz SR, Shaw PA, et al. Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma. Clin Cancer Res. 2018;24(22):5685\u201396.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3310_CR36","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","volume":"30","author":"R Edgar","year":"2002","unstructured":"Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30(1):207\u201310.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"3310_CR37","doi-asserted-by":"publisher","first-page":"D956","DOI":"10.1093\/nar\/gkx1090","volume":"46","author":"SV Vasaikar","year":"2018","unstructured":"Vasaikar SV, Straub P, Wang J, Zhang B. LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res. 2018;46(D1):D956\u201363.","journal-title":"Nucleic Acids Res"},{"issue":"43","key":"3310_CR38","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7629","key":"3310_CR39","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nature19834","volume":"539","author":"MM Kaneda","year":"2016","unstructured":"Kaneda MM, Messer KS, Ralainirina N, Li H, Leem CJ, Gorjestani S, et al. PI3Kgamma is a molecular switch that controls immune suppression. Nature. 2016;539(7629):437\u201342.","journal-title":"Nature"},{"key":"3310_CR40","doi-asserted-by":"publisher","first-page":"5612138","DOI":"10.1155\/2021\/5612138","volume":"2021","author":"Y Hou","year":"2021","unstructured":"Hou Y, Wang S, Gao M, Chang J, Sun J, Qin L, et al. Interferon-Induced Transmembrane Protein 3 Expression Upregulation Is Involved in Progression of Hepatocellular Carcinoma. Biomed Res Int. 2021;2021:5612138.","journal-title":"Biomed Res Int"},{"issue":"10","key":"3310_CR41","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/ni.2705","volume":"14","author":"LC Davies","year":"2013","unstructured":"Davies LC, Jenkins SJ, Allen JE, Taylor PR. Tissue-resident macrophages. Nat Immunol. 2013;14(10):986\u201395.","journal-title":"Nat Immunol"},{"issue":"10","key":"3310_CR42","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.3324\/haematol.2016.143180","volume":"101","author":"YS Al-Matary","year":"2016","unstructured":"Al-Matary YS, Botezatu L, Opalka B, Hones JM, Lams RF, Thivakaran A, et al. Acute myeloid leukemia cells polarize macrophages towards a leukemia supporting state in a Growth factor independence 1 dependent manner. Haematologica. 2016;101(10):1216\u201327.","journal-title":"Haematologica"},{"issue":"3","key":"3310_CR43","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.it.2011.12.001","volume":"33","author":"B Ruffell","year":"2012","unstructured":"Ruffell B, Affara NI, Coussens LM. Differential macrophage programming in the tumor microenvironment. Trends Immunol. 2012;33(3):119\u201326.","journal-title":"Trends Immunol"},{"issue":"3","key":"3310_CR44","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ccr.2013.02.013","volume":"23","author":"M De Palma","year":"2013","unstructured":"De Palma M, Lewis CE. Macrophage regulation of tumor responses to anticancer therapies. Cancer Cell. 2013;23(3):277\u201386.","journal-title":"Cancer Cell"},{"issue":"3","key":"3310_CR45","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1182\/blood-2002-11-3429","volume":"102","author":"Q Xu","year":"2003","unstructured":"Xu Q, Simpson SE, Scialla TJ, Bagg A, Carroll M. Survival of acute myeloid leukemia cells requires PI3 kinase activation. Blood. 2003;102(3):972\u201380.","journal-title":"Blood"},{"issue":"17","key":"3310_CR46","doi-asserted-by":"publisher","first-page":"6247","DOI":"10.3390\/ijms21176247","volume":"21","author":"Y Ruan","year":"2020","unstructured":"Ruan Y, Kim HN, Ogana H, Kim YM. Wnt Signaling in Leukemia and Its Bone Marrow Microenvironment. Int J Mol Sci. 2020;21(17):6247.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3310_CR47","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3390\/ijms24010563","volume":"24","author":"KA Skelding","year":"2022","unstructured":"Skelding KA, Barry DL, Theron DZ, Lincz LF. Bone Marrow Microenvironment as a Source of New Drug Targets for the Treatment of Acute Myeloid Leukaemia. Int J Mol Sci. 2022;24(1):563.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"3310_CR48","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H Dohner","year":"2022","unstructured":"Dohner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140(12):1345\u201377.","journal-title":"Blood"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03310-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03310-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03310-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T03:46:30Z","timestamp":1785123990000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-026-03310-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":48,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["3310"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03310-w","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"14 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"218"}}